The fundamental aspects of the hypothalamic luteinizing hormone-releasing hormone (LHRH)1 [1]pulse generator-pituitary gonadotrophin-gonadal apparatus in mammals have striking commonalities. There are, however, critical, substantive differences in the neuroendocrinology of puberty among species. The onset of puberty in the human is marked by an increase in the amplitude of LH pulses, an indirect indicator of the increase in amplitude of LHRH pulses. The hypothalamic LHRH-pituitary gonadotrophin complex is functional by at least 0.3 gestation in the human foetus; the sex difference in the fetal and neonatal pattern of LH and FSH secretion is an apparent consequence of imprinting of the fetal hypothalamus-pituitary-gonadotropin apparatus by fetal testosterone. Until about 6 months of age in boys and 12–24 months in girls, the testes and ovaries respond to the increased LH in boys and follicle-stimulating hormone (FSH) in girls by secreting testosterone and oestradiol, respectively, reaching levels that are not again achieved before the onset of puberty. Striking features of the ontogeny of the human hypothalamic pulse generator are: (1) its development and function in the foetus; (2) the continued function of the hypothalamic LHRH pulse generator-pituitary gonadotrophin-gonadal axis in infancy; (3) the gradual damping of hypothalamic LHRH oscillator activity during late infancy; (4) its quiescence during childhood – the so-called juvenile pause; (5) during late childhood the gradual disinhibition and reactivation of the LHRH pulse generator, mainly at night; (6) the increasing amplitude of the LHRH pulses, which are reflected in the progressively increased and changing pattern of circulating LH pulses, with the approach of and during puberty. The intrinsic central nervous system (CNS) mechanisms responsible for the inhibition of the LHRH pulse generator during childhood (the juvenile phase) involve the major role of an inhibitory neuronal system – the CNS inhibitory neurotransmitter gamma-aminobutyric acid (GABA) and GABAergic neurons, as revealed by studies in the rhesus monkey by Terasawa and her associates. With the onset of puberty, the disinhibition and reactivation of the LHRH pulse generator is associated with a fall in GABAergic neurotransmission and a concomitant increase in the input of excitatory amino acid neurotransmitters (including glutamate) and possibly astroglial-derived growth factors. Despite remarkable progress over the past three decades, large gaps remain in our understanding of the neurobiological, genetic and environmental mechanisms involved in the control of the onset of puberty. The role of leptin in the control of the onset of puberty is reviewed. Severe leptin deficiency is associated with hypogonadotrophic hypogonadism; it appears that a critical level of leptin and a leptin signal is required to achieve puberty. The weight of evidence supports the hypothesis that leptin acts as one of several permissive factors and not a trigger in the onset of human puberty. The application of these advances provides a framework for the described classification of sexual precocity and delayed puberty.


GnRH is synonymous with LHRH.

Grumbach MM: Onset of puberty; in Berenberg SR (ed): Puberty: Biological and Psychosocial Correlations. Leiden, Stenfert Kroese, 1976, pp 1–21.
Grumbach MM, Styne DM: Puberty: ontogeny, neuroendocrinology, physiology, and disorders; in Wilson JD, Foster DW, Kronenberg HM, Larsen PR (eds): Williams Textbook of Endocrinology, ed 9. Philadelphia, Saunders, 1998, pp 1509–1625.
Ibañez L, DiMartino-Nardi J, Potau N, Saenger P: Premature adrenarche – normal variant or forerunner of adult disease? Endocr Rev 2000;21:671–696.
Grumbach MM, Kaplan SL: The neuroendocrinology of human puberty: an ontogenetic perspective; in Grumbach MM, Sizonenko PC, Aubert ML (eds): Control of the Onset of Puberty. Baltimore, Williams & Wilkins, 1990, pp 1–62.
Knobil E: Remembrance: the discovery of the hypothalamic gonadotropin-releasing hormone pulse generator and of its physiological significance. Endocrinology 1992;131:1005–1006.
Wray S, Grant P, Gainer H: Evidence that cells expressing luteinizing hormone-releasing hormone mRNA in the mouse are derived from progenitor cells in the olfactory placode. Proc Natl Acad Sci USA 1989;86:8132–8136.
Schwanzel-Fukuda M, Crossin KL, Pfaff DW, Bouloux PMG, Hardelin JP, Petit C: Migration of luteinizing hormone-releasing hormone (LHRH) neurons in early human embryos. J Comp Neurol 1996;366:547–557.
Schwanzel-Fukuda M, Bick D, Pfaff DW: Luteinizing hormone-releasing hormone (LHRH)-expressing cells do not migrate normally in an inherited hypogonadal (Kallmann) syndrome. Brain Res Mol Brain Res 1989;6:311–326.
Tobet SA, Bless EP, Schwarting GA: Developmental aspect of the gonadotropin-releasing hormone system. Mol Cell Endocrinol 2001;185:173–184.
Vitalis EA, Costantin JL, Tsai PS, Sakakibara H, Paruthiyil S, Iiri T, Martini J-F, Taga M, Choi AL, Charles AC, Weiner RI: Role of the cAMP signaling pathway in the regulation of gonadotropin-releasing hormone secretion in GT1 cells. Proc Natl Acad Sci USA 2000;97:1861–1866.
Costantin JL, Charles AC: Modulation of Ca(2+) signaling by K(+) channels in a hypothalamic neuronal cell line (GT1-1). J Neurophysiol 2001;85:295–304.
Vazquez-Martinez R, Shorte SL, Boockfor FR, Frawley LS: Synchronized exocytotic bursts from gonadotropin-releasing hormone-expressing cells: dual control by intrinsic cellular pulsatility and gap junctional communication. Endocrinology 2001;142:2095–2101.
Herbison AE, Pae JR, Simonian SX, Skynner MJ, Sim JA: Molecular and cellular properties of GnRH neurons revealed through transgenics in the mouse. Mol Cell Endocrinol 2001:185:185–194.
Pitts GR, Nunemaker CS, Moenter SM: Cycles of transcription and translation do not comprise the gonadotropin-releasing hormone pulse generator in GT1 cells. Endocrinology 2001;142:1858–1864.
Mahachoklertwattana P, Black SM, Kaplan SL, Bristow JD, Grumbach MM: Nitric oxide synthesized by gonadotropin-releasing hormone neurons is a mediator of N-methyl-D-aspartate (NMDA)-induced GnRH secretion. Endocrinology 1994;135:1709–1712.
Moretto M, Lopez FJ, Negro-Vilar A: Nitric oxide regulates luteinizing hormone-releasing hormone secretion. Endocrinology 1993;133:2399–2402.
Grumbach MM, Gluckman PD: The human fetal hypothalamus and pituitary gland: the maturation of neuroendocrine mechanisms controlling the secretion of fetal pituitary growth hormone, prolactin, gonadotropins, adrenocorticotropin-related peptides, and thyrotropin; in Tulchinsky D, Little AB (eds): Maternal-Fetal Endocrinology, ed 2. Philadelphia, Saunders, 1994, pp 193–261.
Reiter EO, Grumbach MM: Neuroendocrine control mechanisms and the onset of puberty. Annu Rev Physiol 1982;44:595–613.
Terasawa E, Fernandez DL: Neurobiological mechanisms of the onset of puberty in primates. Endocr Rev 2001;22:111–151.
Forest MG: Pituitary gonadotropin and sex steroid secretion during the first two years of life; in Grumbach MM, Sizonenko PC, Aubert ML (eds): Control of the Onset of Puberty. Baltimore; Williams & Wilkins, 1990, pp 451–477.
Andersson AM, Toppari J, Haavisto AM, Peterson JH, Simell T, Simell O, Skakkebaek NE: Longitudinal reproductive hormone profiles in infants: Peak of inhibin B levels in infant boys exceeds levels in adult men. J Clin Endocrinol Metab 1998;83:675–681.
Waldhauser F, Weissenbacher G, Frisch H, Pollak A: Pulsatile secretion of gonadotropins in early infancy. Eur J Pediatr 1981;137:71–74.
Plant TM: Puberty in primates; in Knobil E, Neill JD (eds): The Physiology of Reproduction, ed 2. New York, Raven Press, 1994, vol 2, pp 452–485.
Plant TM: Gonadal regulation of hypothalamic gonadotropin-releasing hormone release in primates. Endocr Rev 1986;7:75–88.
Plant TM: Neurobiological bases underlying the control of the onset of puberty in the rhesus monkey: a representative higher primate. Front Neuroendocrinol 2001;22:107–139.
Conte FA, Grumbach MM, Kaplan SL, Reiter EO: Correlation of luteinizing hormone-releasing factor-induced luteinizing hormone and follicle-stimulating hormone release from infancy to 19 years with the changing pattern of gonadotropin secretion in agonadal patients: relation to the restraint of puberty. J Clin Endocrinol Metab 1980;50:163–168.
Conte FA, Grumbach MM, Kaplan SL: A diphasic pattern of gonadotropin secretion in patients with the syndrome of gonadal dysgenesis. J Clin Endocrinol Metab 1975;40:670–674.
Grumbach MM, Roth JC, Kaplan SL, Kelch RP: Hypothalamic-pituitary regulation of puberty in man: evidence and concepts derived from clinical research; in Grumbach MM, Grave GD, Mayer FE (eds): Control of the Onset of Puberty. New York, John Wiley & Sons, 1974, pp 115–181.
Lustig RH, Conte FA, Kogan BA, Grumbach MM: Ontogeny of gonadotropin secretion in congenital anorchism: sexual dimorphism versus syndrome of gonadal dysgenesis and diagnostic considerations. J Urol 1987;138:587–591.
Pohl CR, deRidder CM, Plant TM: Gonadal and nongonadal mechanisms contribute to the prepubertal hiatus in gonadotropin secretion in the female rhesus monkey (Macaca mulatta). J Clin Endocrinol Metab 1995;80:2094–2101.
Martinez de la Escalera G, Choi AL, Weiner RI: Generation and synchronization of gonadotropin-releasing hormone (GnRH) pulses: intrinsic properties of the GT1-1 GnRH neuronal cell line. Proc Natl Acad Sci USA 1992;89:1852–1855.
Terasawa E, Schanhofer WK, Keen KL, Luchansky L: Intracellular Ca(2+) oscillations in luteinizing hormone-releasing hormone neurons derived from the embryonic olfactory placode of the rhesus monkey. J Neurosci 1999;19:5898–5909.
Mitsushima D, Hei DL, Terasawa E: Gamma-aminobutyric acid is an inhibitory neurotransmitter restricting the release of luteinizing hormone-releasing hormone before the onset of puberty. Proc Natl Acad Sci USA 1994;91:395–399.
Mitsushima D, Marzban F, Luchansky LL, Burich AJ, Keen KL, Durning M, Golos TG, Terasawa E: Role of glutamic acid decarboxylase in the prepubertal inhibition of the luteinizing hormone releasing hormone release in female rhesus monkeys. J Neurosci 1996;16:2563–2573.
Kasuya E, Nyberg CL, Mogi K, Terasawa E: A role of gamma-amino butyric acid (GABA) and glutamate in control of puberty in female rhesus monkeys: effect of an antisense oligodeoxynucleotide for GAD67 messenger ribonucleic acid and MK801 on luteinizing hormone-releasing hormone release. Endocrinology 1999;140:705–712.
Keen KL, Burich AJ, Mitsushima D, Kasuya E, Terasawa E: Effects of pulsatile infusion of the GABAA receptor blocker bicuculline on the onset of puberty in female rhesus monkeys. Endocrinology 1999;140:5257–5266.
Hales TG, Sanderson MJ, Charles AC: GABA has excitatory actions on GnRH-secreting immortalized hypothalamic (GT1-7) neurons. Neuroendocrinology 1994;59:297–308.
el-Etr M, Akwa Y, Fiddes RJ, Robel P, Baulieu E-E: A progesterone metabolite stimulates the release of gonadotropin-releasing hormone from GT1-1 hypothalamic neurons via the gamma-aminobutyric acid type A receptor. Proc Natl Acad Sci USA 1995;92:3769–3773.
El Majdoubi ME, Sahu A, Ramaswamy S, Plant TM: Neuropeptide Y: a hypothalamic brake restraining the onset of puberty in primates. Proc Natl Acad Sci USA 2000;97:6179–6184.
Obrietan K, van den Pol AN: GABA neurotransmission in the hypothalamus: Developmental reversal from Ca2+ elevating to depressing. J Neurosci 1995;15:5065–5077.
Terasawa E, Luchansky LL, Kasuya E, Nyberg CL: An increase in glutamate release follows a decrease in gamma-aminobutyric acid and the pubertal increase in luteinizing hormone releasing hormone release in female rhesus monkeys. J Neuroendocrinol 1999;11:275–282.
Plant TM, Gay VL, Marshall GR, Arslan M: Puberty in monkeys is triggered by chemical stimulation of the hypothalamus. Proc Natl Acad Sci USA 1989;86:2506–2510.
Claypool LE, Kasuya E, Saitoh Y, Marzban F, Terasawa E: N-methyl-D,L-aspartate induces the release of luteinizing hormone-releasing hormone in prepubertal and pubertal female rhesus monkey as measured by in vivo push-pull perfusion in the stalk-median eminence. Endocrinology 2000;141:219–228.
Bettendorf M, de Zegher F, Albers N, Hart CS, Kaplan SL, Grumbach MM: Acute N-methyl-D,L-aspartate administration stimulates the luteinizing hormone releasing hormone pulse generator in the ovine fetus. Horm Res 1999;51:25–30.
Mahachoklertwattana P, Sanchez J, Kaplan SL, Grumbach MM: N-methyl-D-aspartate (NMDA) receptors mediate the release of gonadotropin-releasing hormone (GnRH) by NMDA in a hypothalamic GnRH neuronal cell line (GT1-1). Endocrinology 1994;134:1023–1030.
Ojeda SR, Ma YJ: Glial-neuronal interactions in the neuroendocrine control of mammalian puberty: facilitatory effects of gonadal steroids. J Neurobiol 1999;40:528–540.
Ma YJ, Hill DF, Creswick KE, Costa ME, Cornea A, Lioubin MN, Plowman GD, Ojeda SR: Neuregulins signaling via a glial erbB-2-erbB-4 receptor complex contribute to the neuroendocrine control of mammalian sexual development. J Neurosci 1999;9:9913–9927.
Ojeda SR, Ma YJ, Lee BJ, Prevot V: Glia-to-neuron signaling and the neuroendocrine control of female puberty. Recent Prog Horm Res 2000;55:197–223; discussion 223–224.
Jung H, Carmel P, Schwartz MS, Witkin JW, Bentele KHP, Westphal M, Piatt JH, Costa ME, Cornea A, Ma YJ, Ojeda SR: Some hypothalamic hamartomas contain transforming growth factor a, a puberty-inducing growth factor, but not luteinizing hormone-releasing hormone neurons. J Clin Endocrinol Metab 1999;84:4695–4701.
Wu FC, Butler GE, Kelnar CJ, Huhtaniemi I, Veldhuis JD: Ontogeny of pulsatile gonadotropin releasing hormone secretion from midchildhood, through puberty, to adulthood in the human male: a study using deconvolution analysis and an ultrasensitive immunofluorometric assay. J Clin Endocrinol Metab 1996;81:1798–1805.
Mitamura R, Yano K, Suzuki N, Ito Y, Makita Y, Okuno A: Diurnal rhythms of luteinizing hormone, follicle-stimulating hormone, and testosterone secretion before the onset of male puberty. J Clin Endocrinol Metab 1999;84:29–37.
Mitamura R, Yano K, Suzuki N, Ito Y, Makita Y, Okuno A: Diurnal rhythms of luteinizing hormone, follicle-stimulating hormone, testosterone, and estradiol secretion before the onset of female puberty in short children. J Clin Endocrinol Metab 2000;85:1074–1080.
Grumbach MM, Auchus RJ: Estrogen: consequences and implications of human mutations in synthesis and action. J Clin Endocrinol Metab 1999;84:4677–4694.
Hayes FJ, Seminara SB, DeCruz S, Boepple PA, Crowley WF Jr: Aromatase inhibition in the human male reveals a hypothalamic site of estrogen feedback. J Clin Endocrinol Metab 2000;85:3027–3035.
Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM: Positional cloning of the mouse obese gene and its human homologue. Nature 1994;372:425–432. [Erratum, Nature 1995;374:479.]
Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P: Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 1995;269:546–549.
Tartaglia LA, Dembski M, Weng X, Deng N, Culpepper J, Devos R, Richards GJ, Campfield LA, Clark FT, Deeds J: Identification and expression cloning of a leptin receptor, OB-R. Cell 1995;83:1263–1271.
Ahima RS, Saper CB, Flier JS, Elmquist JK: Leptin regulation of neuroendocrine systems. Front Neuroendocrinol 2000;21:263–307.
Wauters M, Considine RV, Van Gaal LF: Human leptin: from an adipocyte hormone to an endocrine mediator. Eur J Endocrinol 2000;143:293–311.
Klein KO, Larmore KA, de Lancey E, Brown JM, Considine RV, Hassink SG: Effect of obesity on estradiol level, and its relationship to leptin, bone maturation, and bone mineral density in children. J Clin Endocrinol Metab 1998;83:3469–3475.
Quinton ND, Smith RF, Clayton PE, Gill MS, Shalet S, Justice SK, Simon SA, Walters S, Postel-Vinay MC, Blakemore AI, Ross RJ: Leptin binding activity changes with age: the link between leptin and puberty. J Clin Endocrinol Metab 1999;84:2336–2341.
Caprio M, Fabbrini E, Isidori AM, Aversa A, Fabbri A: Leptin in reproduction. Trends Endocrinol Metab 2001;12:65–72.
Lee GH, Proenca R, Montez JM, Carroll K, Darvishzadeh JG, Lee JL, Friedman JM: Abnormal splicing of the leptin receptor in diabetic mice. Nature 1996;379:632–635.
Coleman DL: Obese and diabetes: two mutant genes causing diabetes-obesity syndromes in mice. Diabetologia 1978;14:141–148.
Chehab FF, Lim ME, Lu R: Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin. Nat Genet 1996;12:318–320.
Chehab FF: A broader role for leptin. Nat Med 1996;2:723–724.
Chehab FF: Leptin as a regulator of adipose mass and reproduction. Trends Pharmacol Sci 2000;21:309–314.
Mounzih K, Lu R, Chehab FF: Leptin treatment rescues the sterility of genetically obese ob/ob males. Endocrinology 1997;138:1190–1193.
Ahima RS, Dushay J, Flier SN, Prabakaran D, Flier JS: Leptin accelerates the onset of puberty in normal female mice. J Clin Invest 1997;99:391–395.
Bronson FH: Puberty in female mice is not associated with increases in either body fat or leptin. Endocrinology 2001;142:4758–4761.
Chehab FF, Mounzih K, Lu R, Lim ME: Early onset of reproductive function in normal female mice treated with leptin. Science 1997;275:88–90.
Cheung CC, Thornton JE, Kuijper JL, Weigle DS, Clifton DK, Steiner RA: Leptin is a metabolic gate for the onset of puberty in the female rat. Endocrinology 1997;138:855–858.
Gruaz NM, Lalaoui M, Pierroz DD, Englaro P, Sizonenko PC, Blum WF, Aubert ML: Chronic administration of leptin into the lateral ventricle induces sexual maturation in severely food-restricted female rats. J Neuroendocrinol 1998;10:627–633.
Cheung CC, Clifton DK, Steiner RA: Perspectives on leptin’s role as a metabolic signal for the onset of puberty. Front Horm Res 2000;26:87–105.
Magni P, Vettor R, Pagano C, Calcagno A, Beretta E, Messi E, Zanisi M, Martini L, Motta M: Expression of a leptin receptor in immortalized gonadotropin-releasing hormone-secreting neurons. Endocrinology 1999;140:1581–1585.
Zamorano PL, Mahesh VB, De Sevilla LM, Chorich LP, Bhat GK, Brann DW: Expression and localization of the leptin receptor in endocrine and neuroendocrine tissues of the rat. Neuroendocrinology 1997;65:223–228.
Woller M, Tessmer S, Neff D, Nguema AA, Roo BV, Waechter-Brulla D: Leptin stimulates gonadotropin releasing hormone release from cultured intact hemihypothalami and enzymatically dispersed neurons. Exp Biol Med (Maywood) 2001;226:591–596.
Yu WH, Kimura M, Walczewska A, Karanth S, McCann SM: Role of leptin in hypothalamic pituitary function. Proc Natl Acad Sci USA 1997;94:11073–11078.
Plant TM, Durrant AR: Circulating leptin does not appear to provide a signal for triggering the initiation of puberty in the male rhesus monkey (Macaca mulatta). Endocrinology 1997;138:4505–4508.
Urbanski HF, Pau K-Y: A biphasic developmental pattern of circulating leptin in the male rhesus macaque (Macaca mulatta). Endocrinology 1998;139:2284–2286.
Finn PD, Cunningham MJ, Pau K-Y, Spies HG, Clifton DK, Steiner RA: The stimulatory effect of leptin on the neuroendocrine reproductive axis of the monkey. Endocrinology 1998;139:4652–4662.
Cheung CC, Thornton JE, Nurani SD, Clifton DK, Steiner RA: A reassessment of leptin’s role in triggering the onset of puberty in the rat and mouse. Neuroendocrinology 2001;74:12–21.
Mantzoros CS, Flier JS, Rogol AD: A longitudinal assessment of hormonal and physical alterations during normal puberty in boys. V. Rising leptin levels may signal the onset of puberty. J Clin Endocrinol Metab 1997;82:1066–1070.
Clayton PE, Gill MS, Hall CM, Tillmann V, Whatmore AJ, Price DA: Serum leptin through childhood and adolescence. Clin Endocrinol (Oxf) 1997;46:727–733.
Blum WF, Englaro P, Hanitsch S, Juul A, Hertel NT, Muller J, Skakkebaek NE, Heiman ML, Birkett M, Attanasio AM, Kiess W, Rascher W: Plasma leptin levels in healthy children and adolescents: dependence on body mass index, body fat mass, gender, pubertal stage, and testosterone. J Clin Endocrinol Metab 1997;82:2904–2910.
Ahmed ML, Ong KK, Morrell DJ, Cox L, Drayer N, Perry L, Preece MA, Dunger DB: Longitudinal study of leptin concentrations during puberty: sex differences and relationship to changes in body composition. J Clin Endocrinol Metab 1999;84:899–905.
Palmert MR, Radovick S, Boepple PA: The impact of reversible gonadal sex steroid suppression on serum leptin concentrations in children with central precocious puberty. J Clin Endocrinol Metab 1998;83:1091–1096.
Clayton PE, Trueman JA: Leptin and puberty. Arch Dis Child 2000;83:1–4.
Ozata M, Ozdemir IC, Licinio J: Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects. J Clin Endocrinol Metab 1999;84:3686–3695.
Clément K, Vaisse C, Lahlou N, Cabrol S, Pelloux V, Cassuto D, Gourmelen M, Dina C, Chambaz J, Lacorte J-M, Basdevant A, Bougnères P, Lebouc Y, Froguel P, Guy-Grand B: A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 1998;392:398–401.
Farooqi IS, Jebb SA, Langmack G, Lawrence E, Cheetham CH, Prentice AM, Hughes IA, McCamish MA, O’Rahilly S: Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med 1999;341:879–884.
Gill MS, Hall CM, Tillmann V, Clayton PE: Constitutional delay in growth and puberty (CDGP) is associated with hypoleptinaemia. Clin Endocrinol 1999;50:721–726.
Andreelli F, Hanaire-Broutin H, Laville M, Tauber JP, Riou JP, Thivolet C: Normal reproductive function in leptin-deficient patients with lipoatropic diabetes. J Clin Endocrinol Metab 2000;85:715–719.
Grumbach MM: True or central precocious puberty; in Kreiger DT, Bardin CW (eds): Current Therapy in Endocrinology and Metabolism, 1985–1986. Philadelphia, Decker, 1985, pp 4–8.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.